- Home
- KLIC vs IDYA Comparison
KLIC vs IDYA Comparison
Compare KLIC & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KLIC
- IDYA
- Stock Information
- Founded
- KLIC 1951
- IDYA 2015
- Country
- KLIC United States
- IDYA United States
- Employees
- KLIC N/A
- IDYA N/A
- Industry
- KLIC Semiconductors
- IDYA Biotechnology: Pharmaceutical Preparations
- Sector
- KLIC Technology
- IDYA Health Care
- Exchange
- KLIC Nasdaq
- IDYA Nasdaq
- Market Cap
- KLIC 2.0B
- IDYA 2.3B
- IPO Year
- KLIC N/A
- IDYA 2019
- Fundamental
- Price
- KLIC $41.39
- IDYA $29.96
- Analyst Decision
- KLIC Buy
- IDYA Buy
- Analyst Count
- KLIC 4
- IDYA 17
- Target Price
- KLIC $45.00
- IDYA $48.20
- AVG Volume (30 Days)
- KLIC 445.9K
- IDYA 1.3M
- Earning Date
- KLIC 11-12-2025
- IDYA 11-04-2025
- Dividend Yield
- KLIC 2.01%
- IDYA N/A
- EPS Growth
- KLIC N/A
- IDYA N/A
- EPS
- KLIC 0.11
- IDYA N/A
- Revenue
- KLIC $657,842,000.00
- IDYA $7,000,000.00
- Revenue This Year
- KLIC N/A
- IDYA $90.17
- Revenue Next Year
- KLIC $18.61
- IDYA $219.42
- P/E Ratio
- KLIC $357.60
- IDYA N/A
- Revenue Growth
- KLIC N/A
- IDYA N/A
- 52 Week Low
- KLIC $26.63
- IDYA $13.45
- 52 Week High
- KLIC $52.08
- IDYA $32.67
- Technical
- Relative Strength Index (RSI)
- KLIC 57.10
- IDYA 63.91
- Support Level
- KLIC $37.89
- IDYA $28.17
- Resistance Level
- KLIC $40.23
- IDYA $31.07
- Average True Range (ATR)
- KLIC 1.31
- IDYA 1.43
- MACD
- KLIC -0.00
- IDYA 0.10
- Stochastic Oscillator
- KLIC 100.00
- IDYA 77.89
About KLIC Kulicke and Soffa Industries Inc.
Kulicke & Soffa Industries Inc is a United States-based company that is principally engaged in designing, manufacturing, and selling capital equipment and expendable tools that are used for assembling semiconductor devices. The company has four reportable segments which includes Ball Bonding Equipment, Wedge Bonding Equipment, Advanced Solutions, and Aftermarket Products and Services. Its Ball Bonding Equipment segment which generates the majority of the revenue for the company includes results of the company from the design, development, manufacture and sale of ball bonding equipment and wafer level bonding equipment. The majority of its customers are located in the Asia-pacific region.
About IDYA IDEAYA Biosciences Inc.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.